Navigation Links
ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
Date:5/26/2011

z, an allergist/immunologist at the Allergy Clinic of Tulsa in Tulsa, Okla. "Raising awareness of rare disorders is critically important, and may help in the diagnosis of the disease. In addition, a film like this can help assure those dealing with such a rare condition that they are not alone."

This film is one in a series of programs that demonstrates ViroPharma's commitment to raising awareness of hereditary angioedema and to supporting the rare disease community. All of these programs – including Swell -- can be accessed at HAEandME.com.

About Hereditary Angioedema

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States.

For more information on HAE, visit the U.S. HAE Association's website at: www.haea.org.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options.  Our goal is to pro
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
2. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
3. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
4. ViroPharma to Participate In Three May Healthcare Investor Conferences
5. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
6. ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
7. ViroPharma Launches HAE and Me, A New Online Community to Unite People Living With Hereditary Angioedema
8. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
9. ViroPharma Announces Securities Repurchase Program
10. ViroPharma to Participate in Two March Healthcare Conferences
11. ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015 TWi Pharmaceuticals, Inc. ("TWi") (stock ... final approval from the United States Food and ... Application (ANDA) for Guanfacine HCl ER tablet, the ... partner, Par Pharmaceuticals, will launch the product in ... indicated for the treatment of attention deficit hyperactivity ...
(Date:6/2/2015)... 3, 2015 Today, the world,s ... As markets become ever more transparent, the importance of ... recognised long ago. Its maxim of "innovation brings progress ... and digitisation. The company has long been ... of the art" technology and modern approach, while also ...
(Date:6/2/2015)... MENLO PARK, Calif. , June 2, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based solutions ... pricing of an upsized underwritten public offering of its ... per share, before underwriting discounts. The offering consists of ... shares to be sold by certain of its stockholders, ...
Breaking Medicine Technology:Nevro Announces Pricing of Upsized Public Offering of Common Stock 2Nevro Announces Pricing of Upsized Public Offering of Common Stock 3
(Date:6/3/2015)... First Choice Emergency Room , the largest ... States, announced that it is opening its new San ... “I am pleased to announce that we are continuing ... the San Antonio area,” said Dr. James M. Muzzarelli, ... , First Choice Emergency Room is revolutionizing the delivery ...
(Date:6/3/2015)... 03, 2015 “ Scanalytics ” was ... Report, which features the latest and coolest technology products ... the host of NewsWatch, conducted the review and shared ... floor traffic in retail stores. , Tracking statistics in ... When it comes to retail this goes a step ...
(Date:6/3/2015)... ON (PRWEB) June 03, 2015 On ... a Marketing Authorization (MA), effective immediately, which now permits ... foods that contain oats as ingredients. The MA is ... being developed. All stakeholders should be aware that, unlike ... in the USA, there are restrictions for gluten-free oat ...
(Date:6/3/2015)... Fit Body Boot Camp is ... The company helps thousands of individuals across the country lose ... to hit the gym and get the fitness results they ... the most out any gym membership: , Tip #1 – ... gym memberships is saying motivated and on track. Attempting to ...
(Date:6/3/2015)... Washington, DC (PRWEB) June 03, 2015 ... podiatrist Dr. Casey Friske ( Clarksville ... Podiatrist Scholarship from the Symposium of Advanced Wound Care ... by APMA President-Elect Dr. Dan Davis. The Conference ... Henry B. Gonzalez Convention Center in San Antonio, TX. ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2
... ... ... chef supplies company located in Western Massachusetts, found themselves in search of a solution to ... an innovative resolution that not only solved an issue for catering professionals, but a solution ...
... Ore. , Jan. 14 The Tech-Aid Institute, ... work, has released another interactive CD-ROM for people with intellectual ... , With AIDS being the fifth leading cause of death ... States , this interactive computer program helps women with intellectual ...
... , ... medical and surgical equipment supplier — now offers the DRE Velocity EKG, a portable PC-based ... ... a Fast 50 Company by Business First of Louisville —offers the DRE Velocity EKG ...
... , ... VA Goal for Service-Disabled-Veteran-Owned Businesses , ... (PRWEB) January 14, 2010 -- 3D Global Solutions is pleased to announce that it ... award on the $800 million VA Digital Hearing Aid contract. The base year of the ...
... , ... injury attorney, Cliff Blackman, stresses importance of greater awareness of brain injuries and serious ... ... that occurred on New Year,s Day, in which top-ranked American snowboarder Kevin Pearce suffered ...
... ... , ... 2010 -- Morehead, the human capital research firm, will host a ,webinar titled “The ... ,be broadcast on Thursday, February 4, 2010 at 1:00 p.m. EST. , , ,Join ...
Cached Medicine News:Health News:Insulated Transport Containers Go Green 2Health News:The Tech-Aid Institute Releases HIV/AIDS Prevention Software for Women with Intellectual Disabilities 2Health News:Cost-effective PC-based EKG Now Available from DRE 2Health News:Cost-effective PC-based EKG Now Available from DRE 3Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Snowboarding Accident Provides Tragic Reminder of Serious Risk of Brain Injuries in Athletic and Occupational Environments 2Health News:Morehead Presents Webinar on “The State of Physician Engagement: A Year in Review” 2
Foam Cervical Collar is medium-firm density. Breathable. Deeply anatomically contoured. Natural color, 100% cotton stockinette-covered for comfort. 2" hook and loop closures are another mark of quali...
Ezy Wrap® Economy Contour Cervical Collar Medium-density urethane foam. Synthetic white stockinette cover. Reverses for flexion or extension. (Contact closure. Hand wash. Air dry. 10/pack.)...
Exo-Deluxe Overhead Traction for hospital or home care. Twice the clearance of other units between the patient and supporting wall. 2" nylon pulleys with polypropylene cord, head halter, spreader bar...
... Aspen® Cervical Collars improves patient compliance, ... costs. Adjusts to user's anatomy, wicks ... head weight to shoulders and upper ... Front and back airflow openings. Adjustable ...
Medicine Products: